119 related articles for article (PubMed ID: 35863455)
1. Knockout of UBE2S inhibits the proliferation of gastric cancer cells and induces apoptosis by FAS-mediated death receptor pathway.
Zhao R; Yu Z; Mao X; Zheng Y; Wang Y; Zhou Y
Exp Cell Res; 2022 Oct; 419(1):113293. PubMed ID: 35863455
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Investigation into the Role of Ubiquitin-Conjugating Enzyme E2S in Melanoma Development.
Wang P; Li Y; Ma Y; Zhang X; Li Z; Yu W; Zhu M; Wang J; Xu Y; Xu A
J Invest Dermatol; 2021 Feb; 141(2):374-384. PubMed ID: 32603752
[TBL] [Abstract][Full Text] [Related]
3. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
4. UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells.
Liu Z; Xu L
BMB Rep; 2018 Dec; 51(12):642-647. PubMed ID: 30545437
[TBL] [Abstract][Full Text] [Related]
5. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
[TBL] [Abstract][Full Text] [Related]
6. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Downregulates Ubiquitin-Conjugating Enzyme E2S Expression To Prevent Proteasomal Degradation of NS5A, Leading to Host Cells More Sensitive to DNA Damage.
Pham HT; Nguyen TTT; Nguyen LP; Han SS; Lim YS; Hwang SB
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381483
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL.
Liu B; Zhang Y; Fan Y; Wang S; Li Z; Deng M; Li C; Wang J; Ma R; Wang X; Wang Y; Xu L; Hou K; Che X; Liu Y; Qu X
Cancer Sci; 2019 Jul; 110(7):2145-2155. PubMed ID: 31087525
[TBL] [Abstract][Full Text] [Related]
9. UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1.
Tang H; Fang T; Ji M; Wang JP; Song LL; Zhang QY; Wu JS
Biochem Biophys Res Commun; 2021 Nov; 578():7-14. PubMed ID: 34520980
[TBL] [Abstract][Full Text] [Related]
10. UBE2S is associated with malignant characteristics of breast cancer cells.
Ayesha AK; Hyodo T; Asano E; Sato N; Mansour MA; Ito S; Hamaguchi M; Senga T
Tumour Biol; 2016 Jan; 37(1):763-72. PubMed ID: 26245992
[TBL] [Abstract][Full Text] [Related]
11. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.
Xiao K; Peng S; Lu J; Zhou T; Hong X; Chen S; Liu G; Li H; Huang J; Chen X; Lin T
Cell Death Dis; 2023 Jul; 14(7):408. PubMed ID: 37422473
[TBL] [Abstract][Full Text] [Related]
12. UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma.
Gui L; Zhang S; Xu Y; Zhang H; Zhu Y; Kong L
Cell Death Discov; 2021 Nov; 7(1):357. PubMed ID: 34785642
[TBL] [Abstract][Full Text] [Related]
13. UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer.
Lin M; Lei T; Zheng J; Chen S; Du L; Xie H
Int J Biochem Cell Biol; 2019 Apr; 109():17-22. PubMed ID: 30690078
[TBL] [Abstract][Full Text] [Related]
14. A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective.
Bao H; Luo Y; Ding G; Fu Z
J Oncol; 2022; 2022():3982539. PubMed ID: 35578600
[TBL] [Abstract][Full Text] [Related]
15. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
[TBL] [Abstract][Full Text] [Related]
16. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.
Zhang RY; Liu ZK; Wei D; Yong YL; Lin P; Li H; Liu M; Zheng NS; Liu K; Hu CX; Yang XZ; Chen ZN; Bian H
Signal Transduct Target Ther; 2021 Feb; 6(1):64. PubMed ID: 33589597
[TBL] [Abstract][Full Text] [Related]
17. UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway.
Hu W; Li M; Chen Y; Gu X
J Ovarian Res; 2021 Sep; 14(1):121. PubMed ID: 34535173
[TBL] [Abstract][Full Text] [Related]
18. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
[TBL] [Abstract][Full Text] [Related]
19. Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.
Liess AKL; Kucerova A; Schweimer K; Schlesinger D; Dybkov O; Urlaub H; Mansfeld J; Lorenz S
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082289
[TBL] [Abstract][Full Text] [Related]
20. Ube2s-stabilized β-catenin protects against myocardial ischemia/reperfusion injury by activating HIF-1α signaling.
Chen X; Wang C; Yang P; Shi L; Wang H
Aging (Albany NY); 2020 Apr; 12(7):5716-5732. PubMed ID: 32250966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]